Ultraprocessed Food Increases Risk for Death With Type 2 Diabetes
WEDNESDAY, Aug. 2, 2023 (HealthDay News) -- Higher consumption of ultraprocessed food (UPF) is associated with lower survival and higher cardiovascular mortality in patients with type 2 diabetes, according to a study published online July 26 in the American Journal of Clinical Nutrition.
Marialaura Bonaccio, Ph.D., from the IRCCS Istituto Neurologico Mediterraneo Neuromed in Pozzilli, Italy, and colleagues evaluated the association of UPF intake with all-cause and cardiovascular disease (CVD) mortality among 1,065 participants with type 2 diabetes followed for a median of 11.6 years.
The researchers found that greater UPF intake (quartile 4: ≥10.5 percent of total food eaten for women and ≥9 percent for men) versus the lowest (quartile 1: UPF <4.7 and <3.7 percent for women and men, respectively), was associated with a higher risk for both all-cause (hazard ratio, 1.70) and CVD mortality (hazard ratio, 2.64). Associations were not substantially changed with inclusion of the Mediterranean diet score in the model (hazard ratios, 1.64 and 2.55 for all-cause and CVD mortality, respectively). There was a linear dose-response relationship observed between UPF intake with both all-cause and CVD mortality.
"Besides prioritizing the adoption of a diet based on nutritional requirements, dietary guidelines for the management of type 2 diabetes should also recommend limiting UPF," the authors write.
Abstract/Full Text (subscription or payment may be required)
Related Posts
Death During Sex Very Rare Among Those Under 50
THURSDAY, Jan. 13, 2022 (HealthDay News) -- It's a familiar trope of TV and...
Una corte de apelaciones mantiene la cobertura de la atención de salud preventiva de Obamacare, por ahora
MARTES, 16 de mayo de 2023 (HealthDay News) -- Los estadounidenses podrán...
Pediatricians’ Group Urges That All Infants Get New RSV Shot
WEDNESDAY, Aug. 16, 2023 (HealthDay News) -- All infants should receive the new...
Survival Up With Bortezomib in T-Cell Lymphoblastic Lymphoma
FRIDAY, March 25, 2022 (HealthDay News) -- Adding the proteasome inhibitor...